THERAVANCE BIOPHARMA INC

CUSIP: 88339KAA0 Class: NOTE

HBK INVESTMENTS L P's Holding History (CIK: 0001011443)

Note: Option positions (PUT/CALL) are excluded.

Q2 2022
Shares 48,455,000 Value ($000) $44,830 Avg Close — Range —
Q1 2022
Shares 39,945,000 Value ($000) $38,147 Avg Close — Range —
Q4 2021
Shares 34,195,000 Value ($000) $33,023 Avg Close — Range —
Q3 2021
Shares 22,500,000 Value ($000) $20,832 Avg Close — Range —